Intraperitoneal therapy for ovarian cancer: A sacrifice bunt

被引：8

作者：

McGuire, WP

机构：

[1] Univ Mississippi, Sch Med, Jackson, MS 39216 USA

[2] Franklin Sq Hosp, Ctr Canc, Baltimore, MD USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 04期

关键词：

D O I：

10.1200/JCO.2001.19.4.921

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：921 / 923

页数：3

共 12 条

[1] Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer
Alberts, DS
Liu, PY
Hannigan, EV
OToole, R
Williams, SD
Young, JA
Franklin, EW
ClarkePearson, DL
Malviya, VK
DuBeshter, B
Adelson, MD
Hoskins, WJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) : 1950 - 1955
[2] A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with stage II-IV epithelial ovarian cancer following negative surgical assessment
Barakat, RR
Almadrones, L
Venkatraman, ES
Aghajanian, C
Brown, C
Shapiro, F
Curtin, JP
Spriggs, D
[J]. GYNECOLOGIC ONCOLOGY, 1998, 69 (01) : 17 - 22
[3] Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: A randomized trial of the Gruppo Oncologico Noud-Ovest
Gadducci, A
Carnino, F
Chiara, S
Brunetti, I
Tanganelli, L
Romanini, A
Bruzzone, M
Conte, PF
[J]. GYNECOLOGIC ONCOLOGY, 2000, 76 (02) : 157 - 162
[4] JONES RB, 1978, CANCER CHEMOTH PHARM, V1, P161
[5] Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group
Markman, M
Bundy, BN
Alberts, DS
Fowler, JM
Clark-Pearson, DL
Carson, LF
Wadler, S
Sickel, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1001 - 1007
[6] Markman M, 1998, SEMIN ONCOL, V25, P356
[7] Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
McGuire, WP
Hoskins, WJ
Brady, MF
Kucera, PR
Partridge, EE
Look, KY
ClarkePearson, DL
Davidson, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (01) : 1 - 6
[8] How many more nails to seal the coffin of dose intensity?
McGuire, WP
[J]. ANNALS OF ONCOLOGY, 1997, 8 (04) : 311 - 313
[9] Confirmation of the "old" standard of care for ovarian cancer and a challenge
McGuire, WP
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (09) : 674 - 675
[10] MUGGIA FM, 1991, J CLIN ONCOL, V9, P1510, DOI 10.1200/JCO.1991.9.8.1510

← 1 2 →